Suppressed Th17 levels correlate with elevated PIAS3, SHP2, and SOCS3 expression in CD4 T cells during acute simian immunodeficiency virus infection

Journal of Virology

Volumn 87, Issue 12, 2013, Pages 7093-7101

  Bixler, Sandra L ^a   Sandler, Netanya G ^b   Douek, Daniel C ^b   Mattapallil, Joseph J ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 6; KI 67 ANTIGEN; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL LOSS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GENE; GENE EXPRESSION; GENE FUNCTION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INHIBITOR OF ACTIVATED STA3 GENE; REGULATOR GENE; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SRC HOMOLOGY REGION 2 DOMAIN CONTAINING PHOSPHATASE 2 GENE; SUPPRESSOR OF CYTOKINE SIGNALING 3 GENE; TH17 CELL; UPREGULATION; VIRAL PHENOMENA AND FUNCTIONS; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSLOCATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MOLECULAR CHAPERONES; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TH17 CELLS; UP-REGULATION; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84878574716     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00600-13     Document Type: Article

References (66)

1. Douek DC, Picker LJ, Koup RA. 2003. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 21:265-304.
2. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371.
3. Cecchinato V, Trindade CJ, Laurence A, Heraud JM, Brenchley JM, Ferrari MG, Zaffiri L, Tryniszewska E, Tsai WP, Vaccari M, Parks RW, Venzon D, Douek DC, O'Shea JJ, Franchini G. 2008. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 1:279-288.
4. Favre D, Lederer S, Kanwar B, Ma ZM, Proll S, Kasakow Z, Mold J, Swainson L, Barbour JD, Baskin CR, Palermo R, Pandrea I, Miller CJ, Katze MG, McCune JM. 2009. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 5:e1000295. doi:10.1371/journal.ppat.1000295.
5. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, Winter SE, Godinez I, Sankaran S, Paixao TA, Gordon MA, Kolls JK, Dandekar S, Baumler AJ. 2008. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14:421-428.
6. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, Paiardini M, Barclay GR, Smedley J, Pung R, Oliveira KM, Hirsch VM, Silvestri G, Douek DC, Miller CJ, Haase AT, Lifson J, Brenchley JM. 2010. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 6:e1001052. doi:10.1371/journal.ppat.1001052.
7. + lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 5:646-657.
8. Brenchley JM, Paiardini M, Knox KS, Asher AI, Cervasi B, Asher TE, Scheinberg P, Price DA, Hage CA, Kholi LM, Khoruts A, Frank I, Else J, Schacker T, Silvestri G, Douek DC. 2008. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112:2826-2835.
9. Ciccone EJ, Greenwald JH, Lee PI, Biancotto A, Read SW, Yao MA, Hodge JN, Thompson WL, Kovacs SB, Chairez CL, Migueles SA, Kovacs JA, Margolis LB, Sereti I. 2011. CD4 T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors. J. Virol. 85:5880-5888.
10. Eberly MD, Kader M, Hassan W, Rogers KA, Zhou J, Mueller YM, Mattapallil MJ, Piatak M, Jr, Lifson JD, Katsikis PD, Roederer M, Villinger F, Mattapallil JJ. 2009. Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection. J. Immunol. 182:1439-1448.
11. Kaur A, Hale CL, Ramanujan S, Jain RK, Johnson RP. 2000. Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J. Virol. 74: 8413-8424.
12. + T cell dynamics during primary simian immunodeficiency virus infection in macaques: relationship of effector cell differentiation with the extent of viral replication. J. Immunol. 174:6898-6908.
13. Sopper S, Sauer U, Muller JG, Stahl-Hennig C, ter Meulen V. 2000. Early activation and proliferation of T cells in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res. Hum. Retroviruses 16:689-697.
14. Cline AN, Bess JW, Piatak M, Jr, Lifson JD. 2005. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J. Med. Primatol 34:303-312.
15. George J, Cofano EB, Lybarger E, Louder M, Lafont BA, Mascola JR, Robert-Guroff M, Mattapallil JJ. 2011. Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8()FoxP3() T cells in simian immunodeficiency virus-infected controller rhesus macaques. AIDS Res. Hum. Retroviruses 27:763-775.
16. Kader M, Bixler S, Piatak M, Jr, Lifson JD, Mattapallil JJ. 2009. Antiretroviral therapy fails to restore the severe Th-17:Tc-17 imbalance observed during simian immunodeficiency virus infection. J. Med. Primatol. 1:32-38.
17. + but show differential infection based on alpha4beta7 receptor expression during acute SIV infection. J. Med. Primatol. 38(Suppl 1):24-31.
18. Kader M, Hassan WM, Eberly M, Piatak M, Lifson JD, Roederer M, Mattapallil JJ. 2008. Antiretroviral therapy prior to acute viral replication preserves CD4 T cells in the periphery but not in rectal mucosa during acute simian immunodeficiency virus infection. J. Virol. 82:11467-11471.
19. + memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol. 2:439-449.
20. - mononuclear cells are preferentially infected during acute simian immunodeficiency virus infection. J. Virol. 86:1069-1078.
21. Onabajo OO, George J, Lewis MG, Mattapallil JJ. 2013. Rhesus macaque lymph node PD-1(hi)CD4(+) T cells express high levels of CXCR5 and IL-21 and display a CCR7(lo)ICOS(+)Bcl6(+) T-follicular helper (Tfh) cell phenotype. PLoS One 8:e59758. doi:10.1371/journal.pone.0059758.
22. Petrovas C, Yamamoto T, Gerner MY, Boswell KL, Wloka K, Smith EC, Ambrozak DR, Sandler NG, Timmer KJ, Sun X, Pan L, Poholek A, Rao SS, Brenchley JM, Alam SM, Tomaras GD, Roederer M, Douek DC, Seder RA, Germain RN, Haddad EK, Koup RA. 2012. CD4 T follicular helper cell dynamics during SIV infection. J. Clin. Invest. 122:3281-3294.
23. Rozen S, Skaletsky H. 2000. Primer3 on the WWWfor general users and for biologist programmers, p 365-386. In Krawetz S, Misener S, (ed), Bioinformatics methods and protocols in the series methods in molecular biology. Humana Press, Totowa, NJ.
24. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108.
25. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. 2005. Massive infection and loss of memory CD4 T cells in multiple tissues during acute SIV infection. Nature 434:1093-1097.
26. Heumann D, Lauener R, Ryffel B. 2003. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds. J. Endotoxin Res. 9:381-384.
27. Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Furll B, Freudenberg M, Schmitz G, Stelter F, Schutt C. 1997. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 389:742-745.
28. Kitchens RL, Thompson PA. 2005. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J. Endotoxin Res. 11:225-229.
29. Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, Yoshimura A, Hennighausen L, O'Shea JJ. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. U. S. A. 103:8137-8142.
30. Yagil Z, Nechushtan H, Kay G, Yang CM, Kemeny DM, Razin E. 2010. The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response. Trends Immunol. 31:199-204.
31. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942-949.
32. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910-1914.
33. Manel N, Unutmaz D, Littman DR. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9:641-649.
34. Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D. 2008. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3:e2516. doi:10.1371/journal.pone.0002516.
35. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC. 2004. CD4 T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200:749-759.
36. George MD, Sankaran S, Reay E, Gelli AC, Dandekar S. 2003. Highthroughput gene expression profiling indicates dysregulation of intestinal cell cycle mediators and growth factors during primary simian immunodeficiency virus infection. Virology 312:84-94.
37. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, Dandekar S. 2003. Severe CD4 T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77:11708-11717.
38. Heise C, Vogel P, Miller CJ, Halsted CH, Dandekar S. 1993. Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am. J. Pathol. 142:1759-1771.
39. + T cells depletes gut lamina propria CD4 T cells. Nature 434:1148-1152.
40. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M. 2004. Primary HIV-1 infection is associated with preferential depletion of CD4 T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200:761-770.
41. Reka S, Kotler DP. 1998. Correlation of intestinal structure and function in HIV infection. Gastrointest. Endosc. Clin. N. Am. 8:841-856.
42. + T cell depletion and viral replication in SIV infection. Science 280:427-431.
43. Mucida D, Salek-Ardakani S. 2009. Regulation of TH17 cells in the mucosal surfaces. J. Allergy Clin. Immunol. 123:997-1003.
44. Micci L, Cervasi B, Ende ZS, Iriele RI, Reyes-Aviles E, Vinton C, Else J, Silvestri G, Ansari AA, Villinger F, Pahwa S, Estes JD, Brenchley JM, Paiardini M. 2012. Paucity of IL-21-producing CD4(+) T cells is associated with Th17 cell depletion in SIV infection of rhesus macaques. Blood 120:3925-3935.
45. Birx DL, Redfield RR, Tencer K, Fowler A, Burke DS, Tosato G. 1990. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 76:2303-2310.
46. Emilie D, Peuchmaur M, Maillot MC, Crevon MC, Brousse N, Delfraissy JF, Dormont J, Galanaud P. 1990. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J. Clin. Invest. 86:148-159.
47. Pallikkuth S, Pilakka Kanthikeel S, Silva SY, Fischl M, Pahwa R, Pahwa S. 2011. Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy. J. Immunol. 186:6173-6181.
48. Strbo N, de Armas L, Liu H, Kolber MA, Lichtenheld M, Pahwa S. 2008. IL-21 augments natural killer effector functions in chronically HIVinfected individuals. AIDS 22:1551-1560.
49. White L, Krishnan S, Strbo N, Liu H, Kolber MA, Lichtenheld MG, Pahwa RN, Pahwa S. 2007. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood 109: 3873-3880.
50. + T-cell counts. Viral Immunol. 21:385-388.
51. Zhao CC, Xue J, Cong Z, Gao XQ, Zhang WL, Chen T, Wu FX, Xiong J, Ju B, Su A, Wei Q, Qin C. 2013. Circulating IL-21 levels increase during early simian-human immunodeficiency virus infection in macaques. Arch. Virol. 158:853-858.
52. Zhu X, Ma D, Zhang J, Peng J, Qu X, Ji C, Hou M. 2010. Elevated interleukin-21 correlated to Th17 and Th1 cells in patients with immune thrombocytopenia. J. Clin. Immunol. 30:253-259.
53. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K. 1997. Specific inhibition of Stat3 signal transduction by PIAS3. Science 278:1803-1805.
54. Mycko MP, Cichalewska M, Machlanska A, Cwiklinska H, Mariasiewicz M, Selmaj KW. 2012. MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination. Proc. Natl. Acad. Sci. U. S. A. 109:E1248-E1257. doi:10.1073/pnas.1114325109.
55. + Th with a minimum effect on that of Treg in the steady state. Int. Immunol. 19:695-702.
56. Miller RC, Schlaepfer E, Baenziger S, Crameri R, Zeller S, Byland R, Audige A, Nadal D, Speck RF. 2011. HIV interferes with SOCS-1 and -3 expression levels driving immune activation. Eur. J. Immunol. 41:1058-1069.
57. Zhang L, Badgwell DB, Bevers JJ, III, Schlessinger K, Murray PJ, Levy DE, Watowich SS. 2006. IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain. Mol. Cell. Biochem. 288:179-189.
58. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T. 1994. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77:63-71.
59. Ichiba M, Nakajima K, Yamanaka Y, Kiuchi N, Hirano T. 1998. Autoregulation of the Stat3 gene through cooperation with a cAMP-responsive element-binding protein. J. Biol. Chem. 273:6132-6138.
60. + T cells are highly permissive to HIV-1 infection. J. Immunol. 184:1604-1616.
61. Favre D, Mold J, Hunt PW, Kanwar B, Loke P, Seu L, Barbour JD, Lowe MM, Jayawardene A, Aweeka F, Huang Y, Douek DC, Brenchley JM, Martin JN, Hecht FM, Deeks SG, McCune JM. 2010. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med. 2:32ra36. doi:10 .1126/scitranslmed.3000632.
62. Reeves RK, Rajakumar PA, Evans TI, Connole M, Gillis J, Wong FE, Kuzmichev YV, Carville A, Johnson RP. 2011. Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44 mucosal NK cells during SIV infection. Blood 118:3321-3330.
63. Manuzak J, Dillon S, Wilson C. 2012. Differential interleukin-10 (IL-10) and IL-23 production by human blood monocytes and dendritic cells in response to commensal enteric bacteria. Clin. Vaccine Immunol. 19: 1207-1217.
64. Louis S, Dutertre CA, Vimeux L, Fery L, Henno L, Diocou S, Kahi S, Deveau C, Meyer L, Goujard C, Hosmalin A. 2010. IL-23 and IL-12p70 production by monocytes and dendritic cells in primary HIV-1 infection. J. Leukoc. Biol. 87:645-653.
65. Valdez H, Lederman MM. 1997-1998. Cytokines and cytokine therapies in HIV infection. AIDS Clin. Rev. 1997-1998:187-228.
66. Breed MW, Jordan AP, Aye PP, Lichtveld CF, Midkiff CC, Schiro FR, Haggarty BS, Sugimoto C, Alvarez X, Sandler NG, Douek DC, Kuroda MJ, Pahar B, Piatak M, Jr, Lifson JD, Keele BF, Hoxie JA, Lackner AA. 2013. Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progression. J. Virol. 87:1528-1543.